• Complete response of advanced hepatocellular carcinoma to sorafenib : another case and a comprehensi...

• Kim Tae-Suk

• Kim Ji-Hoon, Kim Baek-Hui, Lee Young-Sun, Yoo Yang-Jae, Kang Seong-Hee, Suh Sang-June, Jun...

• Clinical and Molecular Hepatology   2017  Volume.23  No.4 340 ~ 346

• Efficacy and safety of entecavir versus lamivudine over 5 years of treatment: A randomized controlle...

• Lee Kwan-Sik

• Kweon Young-Oh, Um Soon-Ho, Kim Byung-Ho, Lim Young-Suk, Paik Seung-Woon, Heo Jeong, Lee H...

• Clinical and Molecular Hepatology   2017  Volume.23  No.4 331 ~ 339

• Clinical characteristics of patients with chronic hepatitis B who developed genotypic resistance to ...

• Kim Hong-Joo

• Cho Yong-Kyun, Jeon Woo-Kyu, Kim Byung-Ik

• Clinical and Molecular Hepatology   2017  Volume.23  No.4 323 ~ 330

• Efficacy and safety of sofosbuvir-based regimens for treatment in chronic hepatitis C genotype 1 pat...

• Shin Hyun-Phil

• Park Ji-Ae, Burman Blaire, Kozarek Richard A., Siddique Asma

• Clinical and Molecular Hepatology   2017  Volume.23  No.4 316 ~ 322

• Lamivudine: fading into the mists of time

• Choi Jong-Gi

• Lim Young-Suk

• Clinical and Molecular Hepatology   2017  Volume.23  No.4 314 ~ 315

• Is it possible to predict the development of an entecavir resistance mutation in patients with chron...

• Nam Joon-Yeul

• Lee Jeong-Hoon

• Clinical and Molecular Hepatology   2017  Volume.23  No.4 311 ~ 313

• Use of sofosbuvir in chronic kidney disease: Is it necessary?

• Lim Tae-Seop

• Ahn Sang-Hoon

• Clinical and Molecular Hepatology   2017  Volume.23  No.4 308 ~ 310

• Histopathological evaluation of liver fibrosis and cirrhosis regression

• Lo Regina C.

• Kim Hae-Ryoung

• Clinical and Molecular Hepatology   2017  Volume.23  No.4 302 ~ 307

• Imaging evaluation of non-alcoholic fatty liver disease: focused on quantification

• Lee Dong-Ho

• Clinical and Molecular Hepatology   2017  Volume.23  No.4 290 ~ 301

• Contrast-enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS) 2017 ? a revie...

• Kim Tae-Kyoung

• Noh Seung-Yeon, Kono Yuko

• Clinical and Molecular Hepatology   2017  Volume.23  No.4 280 ~ 289

• Treatment options after sorafenib failure in patients with hepatocellular carcinoma

• Dika Imane El

• Abou-Alfa Ghassan K.

• Clinical and Molecular Hepatology   2017  Volume.23  No.4 273 ~ 279

• Recent advances in transarterial embolotherapies in the treatment of hepatocellular carcinoma

• Lee Edward Wolfgang

• Khan Sarah

• Clinical and Molecular Hepatology   2017  Volume.23  No.3 265 ~ 272

• A case of Alagille syndrome presenting with chronic cholestasis in an adult

• Kim Ji-Hye

• Paik Nam-Young, Choe Yon-Ho, Paik Yong-Han

• Clinical and Molecular Hepatology   2017  Volume.23  No.3 260 ~ 264

• Protein and vitamin B6 intake are associated with liver steatosis assessed by transient elastography...

• Ferro Yvelise

• Care Ilaria, Mazza Elisa, Provenzano Francesco, Colica Carmela, Torti Carlo, Romeo Stefano,&nbs...

• Clinical and Molecular Hepatology   2017  Volume.23  No.3 249 ~ 259

• Pitfalls in surveillance for hepatocellular carcinoma: How successful is it in the real world?

• Wong Linda L.

• Reyes Ruel J., Kwee Sandi A., Hernandez Brenda Y., Kalathil Sumodh C., Tsai Naoky C.

• Clinical and Molecular Hepatology   2017  Volume.23  No.3 239 ~ 248

• Efficacy of tenofovir-based rescue therapy for chronic hepatitis B patients with resistance to lamiv...

• Jeon Hee-Jeong

• Jung Seok-Won, Park Neung-Hwa, Yang Yu-Jin, Noh Jin-Hee, Ahn Jae-Sung, Kim Hyung-Rae, Lee ...

• Clinical and Molecular Hepatology   2017  Volume.23  No.3 230 ~ 238

• Influence of ultrasound contrast agents on spectral Doppler analysis in recipients of liver transpla...

• Cho Young-Seo

• Kim Kyoung-Won, Jang Hye-Young, Kim Bo-Hyun, Lee Jeong-Jin, Song Gi-Won, Lee Sung-Gyu

• Clinical and Molecular Hepatology   2017  Volume.23  No.3 224 ~ 229

• Surveillance of hepatocellular carcinoma: is only ultrasound enough?

• Jeong Woo-Kyoung

• Clinical and Molecular Hepatology   2017  Volume.23  No.3 222 ~ 223

• Is tenofovir monotherapy a sufficient defense line against multi-drug resistant hepatitis B virus?

• Lee Yun-Bin

• Lee Jeong-Hoon

• Clinical and Molecular Hepatology   2017  Volume.23  No.3 219 ~ 221

• Current status of and strategies for hepatitis C control in South Korea

• Kim Beom-Kyung

• Jang Eun-Sun, Kim Jeong-Han, Park Soo-Young, Ahn Song-Vogue, Kim Hyung-Joon, Kim Do-Young

• Clinical and Molecular Hepatology   2017  Volume.23  No.3 212 ~ 218